[1]
L. L. . Lema Solano, “Subcutaneous rapid-acting insulin analogs vs. intravenous regular insulin for the treatment of diabetic ketoacidosis. Literature review”, Pentaciencias, vol. 4, no. 6, pp. 44–56, Nov. 2022.